Hung-An Chen

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 359 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Association of Bone Morphogenetic Proteins with Spinal Fusion in Ankylosing Spondylitis

Hung-An Chen, Chun‐Hsiung Chen, Yeong-Jang Lin et al. · The Journal of Rheumatology · 2010 · 69 citations · Full text

Medicine, Orthopaedic Surgery, Radiology +11

Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study

Chien‐Ming Lin, Huiling Huang, Fang-Ying Chu et al. · PLoS ONE · 2015 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3+ Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models

Tzu-Hsuan Wong, Hung-An Chen, Rung‐Jiun Gau et al. · PLoS ONE · 2016 · 55 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Engineering H₂O₂ Self-Supplying Platform for Xdynamic Therapies via Ru–Cu Peroxide Nanocarrier: Tumor Microenvironment-Mediated Synergistic Therapy

Worku Batu Dirersa, Tzu-Chun Kan, Jungshan Chang et al. · ACS Applied Materials & Interfaces · 2024 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17